Thrombocytopenia medical therapy: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
Shyam Patel (talk | contribs) |
||
Line 19: | Line 19: | ||
**Antidote for the offendating agents | **Antidote for the offendating agents | ||
*'''Thrombotic microangiopathy''' | *'''Thrombotic microangiopathy'''<ref name="pmid27149490">{{cite journal| author=Li QY, Yu F, Zhou FD, Zhao MH| title=Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy: A Case Series Study. | journal=Medicine (Baltimore) | year= 2016 | volume= 95 | issue= 18 | pages= e3595 | pmid=27149490 | doi=10.1097/MD.0000000000003595 | pmc=4863807 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27149490 }} </ref> | ||
**Plasma exchange | **Plasma exchange | ||
**Fresh frozen plasma | **Fresh frozen plasma | ||
Line 29: | Line 29: | ||
**Eltrombopag | **Eltrombopag | ||
**Romiplostim | **Romiplostim | ||
==References== | ==References== |
Revision as of 01:03, 20 December 2018
Thrombocytopenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thrombocytopenia medical therapy On the Web |
American Roentgen Ray Society Images of Thrombocytopenia medical therapy |
Risk calculators and risk factors for Thrombocytopenia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]
Overview
The treatment of thrombocytopenia depends on the underlying cause.
Treatment
Supportive measures
- Platelet transfusion
Treatment of the underlying cause
- Viral
- Anti-viral medications
- Hydration and supportive measures
- Drug-induced
- Discontinuation of the offending agent
- Antidote for the offendating agents
- Thrombotic microangiopathy[1]
- Plasma exchange
- Fresh frozen plasma
- Immune thrombocytopenia purpura (ITP)
- Corticosteroids
- Intravenous immunoglobulin
- Fostamatinib
- Eltrombopag
- Romiplostim
References
- ↑ Li QY, Yu F, Zhou FD, Zhao MH (2016). "Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy: A Case Series Study". Medicine (Baltimore). 95 (18): e3595. doi:10.1097/MD.0000000000003595. PMC 4863807. PMID 27149490.